Search Results
Found 1 results
510(k) Data Aggregation
(204 days)
Airvo Nebulizer Adapter
Indications for use - AIRVO nebulizer adapter:
When used with a nebulizer:
The nebulizer adapter is a medical device accessory for single-patient use to facilitate aerosolization of Albuterol sulfate for inhalation to adult patients receiving high-flow humidified breathing gases via tracheostomy patient interface. Intended for use by healthcare professionals in hospitals or long-term care facilities.
When used without a nebulizer:
For use in hospitals and long-term care facilities, for the delivery of humidified respiratory gases to patients via nasal, tracheostomy and mask interfaces.
The Airvo Nebulizer Adapter (hereafter named "nebulizer adapter") is a single use accessory device designed to facilitate aerosolization of a physician-prescribed solution for inhalation to patients receiving high flow humidified breathing gases. The nebulizer adapter is a prescription-only accessory device, provided in a non-sterile state.
The nebulizer adapter is kitted with the AirSpiral tube and MR290 humidification chamber cleared in K162553, to be used in conjunction with Airvo series humidifiers (K131895) along with patient interfaces cleared in K162553.
The device is labelled for use with Salbutamol/ Albuterol only.
Here's a breakdown of the acceptance criteria and study information for the Airvo Nebulizer Adapter, based on the provided FDA 510(k) summary:
This device is a nebulizer adapter, not an AI-powered diagnostic device, so many of the requested categories (like MRMC study, expert qualifications for ground truth, AI improvement effect size, standalone algorithm performance, or training set details) are not applicable. The "ground truth" for this type of medical device largely pertains to its physical and functional performance against established medical device standards and the predicate device, rather than a diagnostic label.
Acceptance Criteria and Reported Device Performance
Device Name: Airvo Nebulizer Adapter
Predicate Device: Aeroneb Solo Nebulizer System / Aeroneb Solo Adapter (K133360)
Acceptance Criteria / Feature | Subject Device (Airvo Nebulizer Adapter) Performance / Characteristic | Predicate Device (Aerogen T-piece) Performance / Characteristic | Comments / Proof of Meeting Criteria |
---|---|---|---|
Premarket Submission | 510(k) K211560 | K133360 | Submitted as a 510(k) |
Product Code | CAF | CAF | Identical |
Device Classification | Class II (21 CFR §868.5630) Anesthesiology | Class II (21 CFR §868.5630) Anesthesiology | Identical |
Intended Use | Attaching a nebulizer system to a breathing circuit for nebulized medication delivery | Attaching a nebulizer system to a breathing circuit for nebulized medication delivery | Identical |
Indications for Use (with nebulizer) | Single-patient use to facilitate aerosolization of Albuterol sulfate for inhalation to adult patients receiving high-flow humidified breathing gases via tracheostomy patient interface. Intended for use by healthcare professionals in hospitals or long-term care facilities. | Portable medical device for single patient use that is intended to aerosolize physician-prescribed solutions for inhalation to patients on and off ventilation or other positive pressure breathing assistance. | Equivalent to predicate. Subject device is a subset (Albuterol only, tracheostomy, high-flow) of the predicate's broader use. |
Indications for Use (without nebulizer) | For use in hospitals and long-term care facilities, for the delivery of humidified respiratory gases to patients via nasal, tracheostomy and mask interfaces. | (N/A for predicate T-piece specifically, but predicate system is for general breathing assistance) | Addressed by the device's design to also function without a nebulizer. |
Availability | Prescription Use (Part 21 CFR 801 Subpart D) | Prescription Use (Part 21 CFR 801 Subpart D) | Identical |
Application | Nebulization within a humidified high flow therapy system | Nebulization within a non-specific breathing support system | Equivalent to predicate; subject device functions within a subset of predicate. Comparative testing done on the two systems shows equivalence of drug delivery to the patient. |
Environment of Use | Hospital | Hospital | Identical |
Connection to Breathing Circuit | Proprietary connectors (Airvo system) | T-piece with 22mm ISO medical tapers (Male inlet and Female outlet) | Different, but performance testing showed equivalence. |
Nebulizer Port Orientation | 15° above horizontal | 15° above horizontal | Identical |
Position in Circuit | Wet side of humidification chamber in single-limb circuit | End of inspiratory limb in a dual-limb circuit or dry side of humidification chamber in a single-limb circuit | Subject device functions within a subset (single-limb only). Comparative testing showed equivalence of drug delivery. |
Sterility | Not provided sterile | Not provided sterile | Identical |
Reusability | Single use | Single use | Identical |
Maximum Duration of Use (with nebulized drugs) | 7 days continuous use | 7 days continuous use | Identical |
Shelf Life | 3 years | Not specified | Favorable (predicate shelf life not specified). |
Flow Path Gas Flow Range (with Albuterol, tracheostomy) | 10 – 30 L/min | Not defined | Favorable (predicate flow range not defined). |
Flow Path Gas Pressure Range | Less than 25 cm H2O | Less than 90 cm H2O | Favorable (subject device range is within predicate range). |
On-label Drugs for Delivery | Salbutamol/Albuterol only | General purpose nebulizer | Subject device is a subset of predicate, which is acceptable. |
Respirable Dose (1-5 µm) from 2500 µg nebule (Albuterol, tracheostomy) | 10 L/min: 1293.1 µg | ||
20 L/min: 949.5 µg | |||
30 L/min: 612.6 µg | 10 L/min: 1339.3 µg | ||
20 L/min: 991.8 µg | |||
30 L/min: 624.4 µg | Equivalent to predicate based on comparative testing. | ||
Median Mass Aerodynamic Diameter (MMAD) (Albuterol, tracheostomy) | 10 L/min: 2.80 µm | ||
20 L/min: 2.73 µm | |||
30 L/min: 2.54 µm | 10 L/min: 2.55 µm | ||
20 L/min: 2.63 µm | |||
30 L/min: 2.59 µm | Equivalent to predicate based on comparative testing. | ||
Compatibility with Tracheal Patient Interface | Yes, Trache patient interface (OPT970) | Yes, when patient intubated through a trachea interface | Equivalent to predicate. |
Shelf Life Simulation | Based on ASTM F1980-07, and ISO 291:2008(E). | (N/A - Not Specified) | Successfully completed. |
Transportation Simulation | Based on ISTA 2A. | (N/A - Not Specified) | Successfully completed. |
Compliance to Standards | ISO 80601-2-74, ISO 10993-1:2018, ISO 18562-1:2017 | (N/A - Not Specified for the specific predicate T-piece) | Successfully completed. |
Nebulizer Performance Testing | Equivalent nebulizing performance when using Airvo nebulizer adapter compared to Aerogen T-piece. | (N/A - Predicate's inherent performance) | Confirmed via performance testing. |
ISO 80601-2-74 Compliance | Airvo system meets requirements when used with nebulizer adapter. | (N/A) | Confirmed via testing. |
Usability | Safe and effective for intended users, uses, and environments. | (N/A) | Confirmed via testing. |
Packaging Integrity | Wear and stresses of distribution do not cause damage. | (N/A) | Confirmed via testing. |
No Adverse Effect on Airvo 2 or AirSpiral tube | Nebulization via port does not adversely affect Airvo 2 or AirSpiral tube. | (N/A) | Confirmed via testing. |
Port Cap Stay in Place | Port cap stays in place during use with Airvo 2 system. | (N/A) | Confirmed via testing. |
Condensate Volume | Total volume of condensate, with potential to reach patient, measured over 24 hours. | (N/A) | Confirmed via testing. |
Study Details
Given this is a 510(k) for a medical device accessory and not an AI/CADe/CADx device, the study information requested regarding human readers, AI assistance, ground truth experts, and training sets is not directly applicable in the context of this submission. The "studies" were primarily non-clinical, benchtop performance, and engineering tests to demonstrate substantial equivalence to the predicate device and compliance with relevant standards.
1. A table of acceptance criteria and the reported device performance:
See table above.
2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective):
The document does not specify exact sample sizes for each non-clinical test (e.g., number of nebulizer adapters tested for respirable dose, number of cycles for shelf life, etc.). The provenance would be the manufacturing site laboratory in New Zealand, and the data is prospective, generated specifically for this submission.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
Not Applicable. For this type of device, "ground truth" is established by adherence to recognized national and international consensus standards (e.g., ASTM, ISO), engineering specifications, and comparative testing against a legally marketed predicate. The "experts" are the engineers and medical device professionals who design and execute these tests and evaluate the results against the defined criteria. Their qualifications would involve expertise in medical device engineering, respiratory therapy, and regulatory affairs.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
Not Applicable. Adjudication methods like 2+1 or 3+1 refer to agreement among multiple human readers for diagnostic truth-finding in image-based AI studies. This is a non-clinical device performance study. Test results are typically reviewed and approved by internal quality and regulatory personnel.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
Not Applicable. This is a physical medical device, not an AI-powered diagnostic tool.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
Not Applicable. This is a physical medical device, not an algorithm. The "standalone" performance would be its mechanical and functional characteristics as tested on a benchtop.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
The "ground truth" for this device is based on:
- Adherence to recognized national and international consensus standards: (e.g., ISO 80601-2-74 for respiratory humidifying equipment, ISO 10993 for biocompatibility, ISO 18562 for breathing gas pathways).
- Performance specifications and engineering requirements: The device's ability to reliably deliver the specified respirable dose and MMAD, maintain pressure, prevent condensate buildup, and ensure component integrity.
- Direct comparative testing against a legally marketed predicate device: Demonstrating that the subject device's performance is equivalent to or better than the predicate's performance in critical aspects (e.g., respirable dose, MMAD).
8. The sample size for the training set:
Not Applicable. This device is not an AI model, so there is no "training set."
9. How the ground truth for the training set was established:
Not Applicable.
Ask a specific question about this device
Page 1 of 1